Amylin touts Ph2 once-monthly exenatide results; Exelixis and BioCryst raising cash; Adamis readies cancer trial;

@FierceBiotech: Analysts jolted by Pharmasset's stellar data on combo hep C treatment. News | Follow @FierceBiotech

@JohnCFierce: I'll be taking off for Rome tomorrow, on way to BIO Europe for biotech panel discussion. Follow @JohnCFierce

> Amylin, Eli Lilly and Alkermes announced positive results from a Phase II study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes. Release

> Exelixis, which has a promising cancer therapy dubbed cabozantinib in Phase III, is raising $165 million through a stock sale. Report

> BioCryst Pharmaceuticals has added to its runway with a $30 million financing deal. Story

> Adamis Pharmaceuticals is recruiting 30 men for the first human clinical trial of its prostate cancer therapy. Story

Pharma News

@FiercePharma: Lilly CEO: No need for megadeals, we have Japan. Story |  Follow @FiercePharma 

> KV's Makena delivers $1,500 sticker shock to docs. Report

> Merck KGaA chief seeks to repair investor relations. Article

> GSK, Human Genome gear up for Benlysta launch. News

> Bloomberg: Pfizer's ex-CEO in running for cabinet post. Report

> Roche keeps up DTC on Boniva while others cut. Story

> U.K. docs: Almost half of J&J hip devices fail after 6 years. Item

Vaccines News

> Cancer vax developer Kite lands $15M. Story

> Gates steps in to vaccine VC with $10M investment. Item 

> Virus present up to one month after Zostavax immunization. Report

> BiovaxID gets EMA orphan status. News 

> Japan: No link between child deaths, vaccines. Article

Manufacturing News

> Bill elevates drug theft to organized crime status. News 

> FDA works to avert cancer drug shortage. Report 

> J&J shortage links eBay to drug supply chain. Item 

> Study finds fuzzy price/drug-quality link. Report 

> Demand, speculators threaten Chinese medicine plants. Article 

And Finally... Researchers have recently shown that, rather than being the silent creatures of popular belief, mice emit ultrasonic calls in a variety of social contexts, and these calls have song-like characteristics. Release